%0 Journal Article
%T Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population
%A Chikako Kiyohara
%A Yoshihiro Miyake
%A Midori Koyanagi
%A Takahiro Fujimoto
%A Senji Shirasawa
%A Keiko Tanaka
%A Wakaba Fukushima
%A Satoshi Sasaki
%A Yoshio Tsuboi
%A Tatsuo Yamada
%A Tomoko Oeda
%A Hiroyuki Shimada
%A Nobutoshi Kawamura
%A Nobutaka Sakae
%A Hidenao Fukuyama
%A Yoshio Hirota
%A Masaki Nagai
%A Fukuoka Kinki Parkinson's Disease Study Group
%J BMC Neurology
%D 2011
%I BioMed Central
%R 10.1186/1471-2377-11-89
%X We investigated the relationship of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), dopamine receptor (DR) D2 and DRD4 polymorphisms and PD risk with special attention to the interaction with cigarette smoking among 238 patients with PD and 369 controls in a Japanese population.Subjects with the AA genotype of MAOB rs1799836 showed a significantly increased risk of PD (odds ratio (OR) = 1.70, 95% confidence interval (CI) = 1.12 - 2.58) compared with the AG and GG genotypes combined. The AA genotype of COMT rs4680 was marginally associated with an increased risk of PD (OR = 1.86, 95% CI = 0.98 - 3.50) compared with the GG genotype. The DRD2 rs1800497 and DRD4 rs1800955 polymorphisms showed no association with PD. A COMT -smoking interaction was suggested, with the combined GA and AA genotypes of rs4680 and non-smoking conferring significantly higher risk (OR = 3.97, 95% CI = 2.13 - 7.41) than the AA genotype and a history of smoking (P for interaction = 0.061). No interactions of smoking with other polymorphisms were observed.The COMT rs4680 and MAOB rs1799836 polymorphisms may increase susceptibility to PD risk among Japanese. Future studies involving larger control and case populations and better pesticide exposure histories will undoubtedly lead to a more thorough understanding of the role of the polymorphisms involved in the dopamine pathway in PD.Dopamine is one of the major modulatory neurotransmitters in the central nervous system (CNS) [1]. As dysfunction of dopaminergic neurotransmission in the CNS has been implicated in development of PD [2], it has been suggested that genetic polymorphisms involved in the biosynthesis and degradation of dopamine and related compounds influence susceptibility to PD. Catechol-O-methyltransferase (COMT) is an enzyme, which by methylation inactivates neurotransmitters and toxic catechols such as the immediate precursor of dopamine. Monoamine oxidase B (MAOB) is one of the primary enzymes regulating metabolism
%U http://www.biomedcentral.com/1471-2377/11/89